Opinion
Video
Author(s):
Toby Maher, MD, PhD, discusses how delays in treatment for idiopathic pulmonary fibrosis (IPF) can significantly worsen patient outcomes and accelerate disease progression, underscoring the critical need for timely intervention.
Video content above is prompted by the following:
How does a delay in treatment affect patient outcomes and disease progression?
KIR2DS2+ NK Cells Show Potential in HCC and Leukemia Treatment